SMi is delighted to announce the return of the 14th annual Controlled Release Delivery conference taking place in London, UK on the 3rd and 4th of April 2017. Aimed at drug development experts and formulation specialists, Controlled Release Delivery 2017 will reflect on the latest innovations made within controlled release.
With a carefully selected panel of industry experts, the 2017 event will address the latest regulatory updates and how to overcome challenges within the industry. Key topics that will be explored include: innovations in drug delivery, nanoparticles/nanomedicine & QbD, CNS drug delivery and therapeutic application.
Speakers include: University Of Strathclyde, Novartis Institutes for BioMedical Research, FDA, Janssen, GSK, Boehringer Ingelheim, Actelion, Merrion Pharmaceuticals and many more...
With a carefully selected panel of industry experts, the 2017 event will address the latest regulatory updates and how to overcome challenges within the industry. Key topics that will be explored include: innovations in drug delivery, nanoparticles/nanomedicine & QbD, CNS drug delivery and therapeutic application.
Speakers include: University Of Strathclyde, Novartis Institutes for BioMedical Research, FDA, Janssen, GSK, Boehringer Ingelheim, Actelion, Merrion Pharmaceuticals and many more...
